An Overview of Viking Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Viking Therapeutics (NASDAQ:VKTX) is set to release its quarterly earnings on October 23, 2024. Analysts expect an EPS of $-0.25. The company's past performance shows significant stock price movements post-earnings, with a notable 28.31% increase last quarter after beating EPS estimates. Shares are currently trading at $64.34, up 484.35% over the past year.
October 22, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Viking Therapeutics is expected to report an EPS of $-0.25. The stock has shown significant price movements post-earnings, with a 28.31% increase last quarter after an EPS beat. Current trading price is $64.34, with a 484.35% increase over the past year.
The anticipation of Viking Therapeutics' earnings release and its history of significant stock price movements post-earnings suggest a likely positive short-term impact if the company beats EPS estimates or provides positive guidance. The stock's strong performance over the past year further supports a bullish outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100